During hyperglycemia, GIP potentiates glucose-induced insulin secretion without exhibiting a glucagonotropic effect (35)

Snapshot of the 2026 Speaker Faculty Top Takeaways: Unlocked the next generation of GLP-1 combinations and gained competitive intelligence on multi-agonist and combination therapies designed to enhance efficacy, minimize muscle loss, and improve body composition for superior patient outcomes Discovered high-value indication expansion and explored the next frontier of GLP-1 development beyond obesity through exclusive data on clinical programs targeting liver, renal and cardiometabolic disorders alongside neurological diseases and womens health conditions Mastered alternative delivery and patient adherence through dedicated sessions focused on overcoming the challenges of administration through oral programs and less frequent dosing strategies for long-term patient success Benchmarked against industry titans and innovators and heard directly from the companies leading the pipeline, including experts from Eli Lilly , Constructive Bio and Regeneron

Methods We conducted integrated analyses of the liver transcriptome (n=131) and DNA methylome (n=106) of patients with biopsy-proven MASLD
Similarly a study conducted in 2023 also confirmed that while Tirzepatide preserves weight loss with continued use, withdrawal also leads to substantial regain in clinical trials (34)
The power of lipotropic injection therapy
A comprehensive medical intake will be completed to assess medical history, ensure safety, and screen for any contraindications to treatment